Skip to main content

Table 3 Clinical and demographic characteristics stratified according awareness of hypoglycemia evaluated by the Clarke and Gold questionnaires

From: Hypoglycemia symptoms and awareness of hypoglycemia in type 1 diabetes mellitus: cross-cultural adaptation and validation of the Portuguese version of three questionnaires and evaluation of its risk factors

 ClarkeGold
Aware (n = 76)IAH (n = 47)pAware (n = 92)IAH (n = 31)p
IAH (%)61.738.3 74.825.2 
Sex (% male)33.117.9 42.38.9 
Age38.01 (11.16)42.09 (11.73)0.06039.2 (11.25)40.68 (12.36)0.558
BMI24.19 (3.42)24.56 (3.59)0.56824.17 (3.42)24.81 (3,60)0.390
Diabetes duration20.17 (10.21)25.91 (9.29)0.00221.53 (10.32)24.84 (9.64)0.110
Insulin dose0.72 (0.23)0.69 (0.20)0.4670.71 (0.22)0.69 (0.20)0.640
Glycaemia191.79 (106.53)166.43 (102.62)0.196192.61 (110.8)150.9 (80.9)0.028
HbA1C (%)8.62 (1.52)8.09 (1.36)0.0478.52 (1.49)8.13 (1.41)0.199
GFRe (mL/min/1,73 m2)84.05 (36,4)59.96 (40,68)0.00175.82 (39.55)71.97 (40.65)0.648
No of hypoglycemia/week2.2 (1.53)3.43 (1.97)0.0002.38 (1.64)3.52 (2.03)0.007
No severe hypoglycemia in 6 m0.93 (1.82)3.74 (3.27)0.0001.43 (2.13)3.71 (3.81)0.003
No severe hypoglycemia in 12 m2.05 (3.97)7.28 (6.10)0.0003.12 (4.71)6.81 (6.70)0.001
Intravenous glucose need0.11 (0.32)0.63 (0.48)0.0000.25 (0.43)0.5161 (0.50)0.006
  1. Variables are described as mean (SD) or percentage (%)